Björn Wängler
German Cancer Research Center
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Björn Wängler.
European Journal of Nuclear Medicine and Molecular Imaging | 2008
Matthias Eder; Björn Wängler; Stefan Knackmuss; Fabrice LeGall; Melvyn Little; Uwe Haberkorn; Walter Mier; Michael Eisenhut
PurposeThe success of 68Ga-labeled peptides for positron emission tomography of neuroendocrine tumors is mainly depending on the complex chemistry of this radioisotope. 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA), the chelator of choice has however limitations if its application is expanded to heat-sensitive proteins. Recombinant antibodies like single chain Fv or diabodies belong to this class of proteins. They are suited to provide imaging contrast despite the short-lived 68Ga because of their rapid blood clearances and nanomolar affinities. The heterobifunctional agent N,N′-bis[2-hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-N,N′-diacetic acid (HBED-CC) was chosen as an alternative ligand because this agent is complexing [68Ga]Ga3+ much faster than DOTA at ambient temperatures.Materials and methodsA versatile technology for HBED-CC conjugation of proteins and 68Ga-labeling has been developed. This included HBED-CC–tetrafluorophenol (TFP) ester synthesis, coupling to the antibody at various pH and complexation reactions performed in 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) buffer under different conditions.ResultsThe synthesis of the monoreactive 2,3,5,6-tetrafluorophenolate of HBED-CC at a carboxyl group not participating in complex formation used [Fe(HBED-CC)]− for ester formation. The removal of Fe3+ from purified (HBED-CC)TFP ester was achieved with RP18 cartridge technology. The conjugation chemistry was performed with mAb425 which binds to the epidermal growth factor receptor (EGFR). This protein was used for optimizing purposes only. The influence of complexation parameters like temperature, pH, reaction time, and HBED-CC/antibody ratio on the biological activity of this model antibody was investigated. Furthermore, the outcome of this labeling procedure on the biological activity of a recombinant diabody (50xa0kDa) was studied.ConclusionIt is known that small HBED-CC/antibody ratios are prerequisites for minimal interference of labels with antigen-binding domains. Here, the coupling of about one HBED-CC per antibody proved to be sufficient for efficient 68Ga labeling, pointing to the successful application of 68Ga for molecular imaging with small recombinant proteins.
Langmuir | 2007
Chunfu Zhang; Björn Wängler; Bernd Morgenstern; Hanswalter Zentgraf; Michael Eisenhut; Harald Untenecker; Ralf Krüger; Ralf Huss; Christian Seliger; Wolfhard Semmler; Fabian Kiessling
Bioorganic & Medicinal Chemistry | 2008
C. Wängler; Björn Wängler; Michael Eisenhut; Uwe Haberkorn; Walter Mier
Tetrahedron Letters | 2006
Björn Wängler; Carmen Beck; Ulrike Wagner-Utermann; Esther Schirrmacher; Claudia Bauer; Frank Rösch; Ralf Schirrmacher; Michael Eisenhut
Faculty of Health; School of Psychology & Counselling | 2012
Erik Mille; Paul Cumming; Axel Rominger; Christian la Fougère; Klaus Tatsch; Björn Wängler; Peter Bartenstein; Guido Böning
Archive | 2007
Manfred Jugold; Fabian Kiessling; Chunfu Zhang; Björn Wängler; Rüdiger Pipkorn; Wohlfhard Semmler
Society of Nuclear Medicine Annual Meeting Abstracts | 2010
Axel Rominger; Björn Wängler; Peter Bartenstein; Paul Cumming
Archive | 2019
Ralf Schirrmacher; Vadim Bernard-Gauthier; Esther Schirrmacher; Justin J. Bailey; Klaus Jurkschat; Carmen Wängler; Björn Wängler
Archive | 2017
Justin J. Bailey; Carmen Wängler; Björn Wängler; Ralf Schirrmacher
Archive | 2014
Carmen Wängler; Petia Djurova; Björn Wängler; Gert Fricker